ArticleFrontiers in toxicology2026
Visual-acoustic thigmotaxis in zebrafish larvae: a high throughput NAM for neurotoxicity assessment.
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Current regulatory neurotoxicity guidelines do not include behavioral endpoints that capture stress-related responses. Zebrafish larvae prior to independent feeding offer a promising vertebrate model for developing new approach methodologies (NAMs) because they combine neurobiological relevance with high-throughput potential. In this study, we developed and evaluated a larval thigmotaxis assay to detect behavioral alterations induced by neuroactive substances. Methods: Zebrafish larvae at 120 hpf were exposed for 1 h to model compounds and then challenged with visual (light/dark) and acoustic (tapping/silence) stimuli. Thigmotaxis, defined as edge-preference behavior, and locomotor activity were assessed. To increase throughput, we compared the conventional 24-round-well format with a 96-square-well format. Assay performance was evaluated using caffeine and diazepam as reference compounds, followed by additional neuroactive substances (chlorpyrifos, nicotine, dexamethasone, ethylenethiourea) and low-neuroactivity comparators (saccharin, amoxicillin). Benchmark dose modeling was used to compare the sensitivity of thigmotaxis and locomotor endpoints. Results: The 24-well and 96-well formats produced equivalent results, supporting use of the higher-throughput system. Reference compounds confirmed assay performance, with caffeine increasing thigmotaxis and diazepam decreasing it under specific stimulus conditions. Additional neuroactive substances produced stimulus-dependent behavioral responses, whereas saccharin and amoxicillin caused little or no effect. Across compounds, benchmark dose modeling showed that thigmotaxis was generally more sensitive than traditional locomotor activity endpoints. Discussion: This multiplexed visual-acoustic thigmotaxis assay is reproducible, scalable, and sensitive for detecting neuroactive effects in zebrafish larvae. It can be used either as a stand-alone behavioral NAM or integrated into a broader test battery for neurotoxicity assessment. The method provides a practical and ethical tool to support chemical safety assessment in both ecotoxicology and human toxicology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.